21
Jun
2010
Posted in I - Series F, Q - 2Q10, R - WEST, X - Device (Sequencing), XX - CA
Pacific Biosciences (Menlo Park, CA) developer of single molecule real-time nucleic acid and protein sequencing system closed a $50M Series F financing. Participants include Gen-Probe, Monsanto, the Wellcome Trust, Sutter Hill Ventures, Deerfield Management, Intel Capital, Morgan Stanley, Redmile Group, T. Rowe Price, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures, Maverick Capital, [...]
11
Jun
2010
20
May
2010
Posted in I - Series C, Q - 2Q10, R - WEST, X - Device (COPD), X - Device (Sleep Apnea), XX - CA
Breathe Technologies (San Ramon, CA) a commercial-stage medical device company focused on therapeutic respiratory systems for the treatment of COPD and sleep apnea, closed a $23M Series C financing. Participants include DAG Ventures, Kleiner Perkins Caufield & Byers, Delphi Ventures, Synergy Ventures and Johnson & Johnson Development Corp..
17
May
2010
Posted in I - Series D, Q - 2Q10, R - WEST, X - Device (Cardiology), XX - CA
CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $5M Series D financing, bring the total round to $34.5M. Participants include GE Healthymagination Fund, Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, Mohr Davidow Ventures, DAG Ventures, Pappas Ventures and Asset [...]
11
May
2010
Posted in I - Series B, Q - 2Q10, R - WEST, X - Biofuel, XX - CA
EdenIQ (Visalia, CA) a commercial-stage biofuel company focused on lignocellulosic material to boost ethanol yields from corn and sugarcane, closed a $12.4M Series B financing. Participants include Draper Fisher Jurvetson, Westly Group, Kleiner Perkins Caufield & Byers, Cyrus Capital Partners, Angeleno Group, Element Partners, Morgan Stanley, Advanced Equities, Omninet and Nimes Capital.
12
Apr
2010
Posted in I - Series B, Q - 1Q10, R - WEST, X - Influenza, X - Leukemia, X - Vaccines, XX - CA
Juvaris BioTherapeutics (Burlingame, CA) a clinical-stage biopharma company focused on adjuvanted vaccines for seasonal flu and immunotherapeutics for Leukemia and animal health, closed a $12.5M Series B financing, bringing the total round to $25M. Participants include Kleiner Perkins Caufield & Byers, SV Life Sciences and an undisclosed corporate partner.
30
Mar
2010
Posted in I - Series E, Q - 1Q10, R - NORTH EAST, X - Device (Organ Transplant), XX - MA
TransMedics (Andover, MA) a clinical-stage medical device company focused on a technology platform to maintain donor organs in near-physiologic and functioning condition during transport for organ transplantation, closed a $36M Series E financing. Participants include Foundation Capital, Kleiner Perkins Caufield & Byers, Flagship Ventures, 3i Group, Tudor Investment, VantagePoint Venture Partners, Sherbrooke Partners, Alta Partners, [...]
23
Mar
2010
Posted in I - Series D, Q - 1Q10, R - WEST, X - Device (Diagnostic), XX - CA
Nodality (San Francisco, CA) a development-stage molecular diagnostics company focused on hematological malignancies and autoimmune disorders, closed a $15.5M Series D financing. Participants include Pfizer Venture Investments, Laboratory Corp of America Holdings, Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Growth.
18
Mar
2010
Posted in Uncategorized
08
Mar
2010
Posted in I - Series C, Q - 1Q10, R - WEST, X - Device (COPD), X - Device (Pulmonary), XX - CA
Pulmonx (Redwood City, CA) a commercial-stage medical device company focused on minimally invasive devices for the diagnosis and treatment of COPD and other pulmonary disorders, closed a $32M Series C financing. Participants include HealthCap, Kleiner Perkins Caufield & Byers, De Novo Ventures, Latterell Venture Partners, MedVenture Associates, Montreux Equity Partners and Posco BioVentures.